Trials / Completed
CompletedNCT02033096
Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
A 4-Year Follow-up, Blinded-Outcomes Trial of Subjects Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · Industry
- Sex
- All
- Age
- 30 Days – 4 Years
- Healthy volunteers
- Not accepted
Summary
Observational follow-up of participants from earlier interventional trial 64,185-202 (NCT00850993). No interventions were administered during this follow-up study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stannsoporfin | No intervention was administered during this observational study |
| DRUG | Placebo Control | No intervention was administered during this observational study |
| OTHER | Phototherapy (as needed) | No intervention was administered during this observational study |
Timeline
- Start date
- 2008-10-20
- Primary completion
- 2015-06-23
- Completion
- 2015-11-09
- First posted
- 2014-01-10
- Last updated
- 2019-10-15
Source: ClinicalTrials.gov record NCT02033096. Inclusion in this directory is not an endorsement.